Get Fit Bharat

Tag: Sculpting

HomeSculpting

STOCKHOLM, SWEDEN - January 16, 2025 – OncoZenge AB (publ) (“OncoZenge” or the “Company”), announces the filing of a patent application under the Patent Cooperation Treaty (PCT) process, a significant milestone in the intellectual property strategy for the company’s lead drug candidate, BupiZenge™. This filing follows the patent application submitted with …

TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN BMG702782084 Issuer Name PETRA DIAMONDS LIMITED UK or Non-UK Issuer Non-UK 2. Reason for Notification An acquisition or disposal of voting rights 3. Details of person subject to the notification obligation Name Vontobel Hol City of registered office …

The world of cryptocurrencies is ever-changing, and meme coins have recently surged in popularity due to their unique blend of fun, community, and sometimes absurdity. However, UNCO Meme Coin stands out in a crowded space, combining humor with tangible value. This Ethereum-based meme coin is creating waves by introducing an innovative approach that goes beyond …

DENSO, a leading global mobility supplier, is excited to announce its participation in the Bharat Mobility Global Expo 2025, taking place from January 17th to 22nd, 2025, at Bharat Mandapam, Pragati Maidan, New Delhi. This platform reflects the growing capabilities and innovations within the Indian automotive sector.    DENSO's exhibition is located …

New York, United States:  Diligent, a leading GRC SaaS company, today announced it is collaborating with S&P Global’s Market Intelligence division to launch Diligent Market Insights Reporting. Powered by S&P Capital IQ Pro data, the reports give corporate directors and executives timely, contextualized insights into global financial data and peer performance …

Saniona has announced that Cephagenix, a joint venture with Professor Jes Olesen at the University of Copenhagen, has successfully raised up to 9 MEUR  in tranched seed financing. The funding round was led by AdBio Partners and AbbVie Ventures and aims to accelerate the development of Cephagenix’s vascular KATP channel inhibitor …